119 related articles for article (PubMed ID: 36730009)
1. Apoptotic and autophagic cell death induced in cervical cancer cells by a dual specific oncolytic adenovirus.
Li S; Li Z; Chen S; Zhu Y; Li Y; Yin X; Li X; Zhu G
Anticancer Drugs; 2023 Mar; 34(3):361-372. PubMed ID: 36730009
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
3. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
[TBL] [Abstract][Full Text] [Related]
4. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
[TBL] [Abstract][Full Text] [Related]
5. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
6. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.
Li X; Liu Y; Wen Z; Li C; Lu H; Tian M; Jin K; Sun L; Gao P; Yang E; Xu X; Kan S; Wang Z; Wang Y; Jin N
Mol Cancer; 2010 Jan; 9():10. PubMed ID: 20085660
[TBL] [Abstract][Full Text] [Related]
7. Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models.
Shang C; Zhu YL; Li YQ; Song GJ; Ge CC; Lu J; Xiu ZR; Li WJ; Li SZ; Cong JN; Liu ZR; Li X; Sun LL; Jin NY
Invest New Drugs; 2021 Aug; 39(4):949-960. PubMed ID: 33534026
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adenoviruses expressing apoptin suppress the growth of MCF‑7 breast cancer cells and affect cell autophagy.
Chen S; Li YQ; Yin XZ; Li SZ; Zhu YL; Fan YY; Li WJ; Cui YL; Zhao J; Li X; Zhang QG; Jin NY
Oncol Rep; 2019 May; 41(5):2818-2832. PubMed ID: 30896879
[TBL] [Abstract][Full Text] [Related]
9. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.
Hasei J; Sasaki T; Tazawa H; Osaki S; Yamakawa Y; Kunisada T; Yoshida A; Hashimoto Y; Onishi T; Uno F; Kagawa S; Urata Y; Ozaki T; Fujiwara T
Mol Cancer Ther; 2013 Mar; 12(3):314-25. PubMed ID: 23315976
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer
Yang G; Meng X; Sun L; Hu N; Jiang S; Sheng Y; Chen Z; Zhou Y; Chen D; Li X; Jin N
Exp Ther Med; 2015 Feb; 9(2):327-334. PubMed ID: 25574193
[TBL] [Abstract][Full Text] [Related]
11. Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
Tazawa H; Kuroda S; Hasei J; Kagawa S; Fujiwara T
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698504
[TBL] [Abstract][Full Text] [Related]
12. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Tumor Effect of a Novel Oncolytic Virus Based on Chimpanzee Adenovirus Type 6].
Wang Q; Wang YH; Li Y; Xing M; Zhou DM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):71-76. PubMed ID: 35048603
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells.
Cui Y; Li Y; Li S; Li W; Zhu Y; Wang J; Liu X; Yue Y; Jin N; Li X
Exp Cell Res; 2020 Nov; 396(1):112185. PubMed ID: 32828827
[TBL] [Abstract][Full Text] [Related]
15. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro.
Tian Y; Yao W; He D; Xu Y; Li Y; Zhu Y; Fang J; Bai B; Li X; Sun L; Jin N
Anticancer Drugs; 2020 Feb; 31(2):110-122. PubMed ID: 31658131
[TBL] [Abstract][Full Text] [Related]
16. Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.
Zhang M; Wang J; Li C; Hu N; Wang K; Ji H; He D; Quan C; Li X; Jin N; Li Y
Int J Oncol; 2013 Mar; 42(3):1052-60. PubMed ID: 23338489
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus.
Qi Y; Guo H; Hu N; He D; Zhang S; Chu Y; Huang Y; Li X; Sun L; Jin N
Toxicol Appl Pharmacol; 2014 Oct; 280(2):362-9. PubMed ID: 25151223
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
Tazawa H; Kagawa S; Fujiwara T
Acta Med Okayama; 2013; 67(6):333-42. PubMed ID: 24356717
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS
Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
